The resolution designates September of each year as "Duchenne Muscular Dystrophy Awareness Month" in New Jersey to raise awareness about Duchenne muscular dystrophy (DMD), a severe genetic disorder affecting approximately 1 in 3,500 male infants. DMD leads to progressive muscle degeneration, resulting in significant loss of mobility and life-threatening complications, with an average life expectancy of just 25 years. While there is currently no cure, advancements in medical research and treatment options, including gene therapy and stem cell-based therapies, offer hope for better management of the disease. Non-profit organizations in New Jersey are actively working to improve care, advocate for patients, and fund research.

The resolution calls for the Governor to issue an annual proclamation recognizing September as DMD Awareness Month and encourages state agencies, organizations, and citizens to participate in awareness activities and programs. By designating this month, the resolution aims to promote empathy, understanding, and community support for individuals and families affected by DMD, while also emphasizing the importance of early diagnosis and access to optimal care to potentially extend life expectancy for those living with the condition.